These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15903006

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy.
    Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC.
    Epilepsy Res; 1990 Aug; 6(3):221-6. PubMed ID: 2272345
    [Abstract] [Full Text] [Related]

  • 23. Lamotrigine and valproate: efficacy of co-administration in a pediatric population.
    Thomé-Souza S, Freitas A, Fiore LA, Valente KD.
    Pediatr Neurol; 2003 May; 28(5):360-4. PubMed ID: 12878297
    [Abstract] [Full Text] [Related]

  • 24. Hypersensitivity to lamotrigine and nonaromatic anticonvulsant drugs: a review.
    Gaeta F, Alonzi C, Valluzzi RL, Viola M, Elia M, Romano A.
    Curr Pharm Des; 2008 May; 14(27):2874-82. PubMed ID: 18991705
    [Abstract] [Full Text] [Related]

  • 25. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD.
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Add-on lamotrigine in pediatric epilepsy in India.
    Jain R, Mishra D, Juneja M.
    Indian Pediatr; 2011 Jan; 48(1):55-8. PubMed ID: 20453261
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N, Besag F, Iivanainen M.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Stevens-Johnson syndrome after lamotrigine treatment].
    Campistol J, Geli M, Llistosella E, Molins J, Llobet M.
    Rev Neurol; 1995 Dec; 23(124):1236-8. PubMed ID: 8556627
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
    Petkov T, Pehlivanov G, Grozdev I, Kavaklieva S, Tsankov N.
    Eur J Dermatol; 2007 Dec; 17(5):422-7. PubMed ID: 17673387
    [Abstract] [Full Text] [Related]

  • 36. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.
    Brodie MJ, Overstall PW, Giorgi L.
    Epilepsy Res; 1999 Oct; 37(1):81-7. PubMed ID: 10515178
    [Abstract] [Full Text] [Related]

  • 37. Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder.
    Herold TJ.
    CJEM; 2006 Sep; 8(5):361-4. PubMed ID: 17338851
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product.
    Sabroe TP, Sabers A.
    Acta Neurol Scand; 2008 Jun; 117(6):428-31. PubMed ID: 18205884
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.